Pomalidomide medical insurance price

Pomalidomide is a cancer drug used to treat multiple myeloma (a cancer of the bone marrow) in combination with bortezomib (another cancer drug) and dexamethasone (an anti-inflammatory drug) in adults who have received at least one treatment including lenalidomide (another cancer drug). It is also used in combination with dexamethasone in adults whose disease has worsened after at least two prior treatments, including lenalidomide and bortezomib. Pomalidomidecontains the active substance pomalidomide, which is an immunomodulator. This means it affects the activity of the immune system (the body's natural defense system). Pomalidomide works in multiple ways in multiple myeloma, similar to other immunomodulatory drugs such as lenalidomide and thalidomide. It blocks the development of tumor cells, prevents the growth of blood vessels within tumors, and stimulates some specialized cells of the immune system to attack tumor cells.

Pomalidomide, independently developed in China, has been launched in the country and has now entered the scope of medical insurance. The price of each box of domestically produced pomalidomide may be around RMB 4,000. The reimbursement ratio and post-reimbursement price may differ in different regions. Domestic hospitals or pharmacies may sell this drug. The price of each box of the Turkish version listed overseas may be around 15,000 yuan (the price may fluctuate due to exchange rates), which is relatively expensive. There are also cheaper generic drugs produced in other countries overseas. The price of each box produced by a Lao pharmaceutical factory may be around a few hundred yuan (the price may fluctuate due to the exchange rate). The ingredients of foreign generic drugs, domestically produced drugs and foreign original drugs are basically the same. For more drug information and specific prices, please consult Yaode Medical Consultant.